Eugene Schneider, EVP, Chf Clinical Develop Ofcr at IONIS PHARMACEUTICALS INC (IONS), sold 39,316 shares at $60.46 ($2.4M) on 2025-09-03, disclosed to the SEC on 2025-09-04.
Scheduled sale ($2.4M) by EVP, Chf Clinical Develop Ofcr under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.46 | 12,455 | $753K | 31.5% |
| 2 | $60.46 | 12,455 | $753K | 31.5% |
| 3 | $61.42 | 7,203 | $442K | 18.5% |
| 4 | $61.42 | 7,203 | $442K | 18.5% |
| Total | $60.81 avg | 39,316 | $2.4M | 100% |
| Filing → |
| IONS | SELL | 2026-02-02 | $516K | — | Filing → |
| IONS | SELL | 2026-01-20 | $703K | — | Filing → |
| IONS | SELL | 2025-08-05 | $817K | — | Filing → |